Clinical Trial Update: A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease [Phase 4]

View source ↗

Summary

A Phase 4, randomized, placebo-controlled, cross-over trial assessing the effects of the probiotic VSL#3 on metabolic profile, intestinal permeability, microbio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• VSL#3

Snippet

Sponsor: Federico II University | Conditions: Crohn's Disease | Phase 4 | Status: UNKNOWN